Truist Securities Reiterates Buy on American Healthcares, Raises Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has reiterated its Buy rating on American Healthcares (NYSE:AHR) and raised the price target from $16 to $17.
July 01, 2024 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has reiterated its Buy rating on American Healthcares (NYSE:AHR) and raised the price target from $16 to $17.
The reiteration of a Buy rating and an increase in the price target from a reputable analyst can positively influence investor sentiment and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100